Up until now, only a few studies have examined the role of SEMA6A in cancer biology19, and only one study reported that the extracellular region of SEMA6A could inhibit tumor formation via decreasing VEGF-induced xenograft vascularization20. The gene discussed is SEMA6A; the disease is cancer.